Direkt zum Inhalt
Merck

Breaking the cycle of medication overuse headache.

Cleveland Clinic journal of medicine (2010-04-03)
Stewart J Tepper, Deborah E Tepper
ZUSAMMENFASSUNG

When patients who have frequent, disabling migraines take medications to relieve their symptoms, they run the risk that the attacks will increase in frequency to daily or near-daily as a rebound effect comes into play. This pattern, called medication overuse headache, is more likely to happen with butalbital and opioids than with migraine-specific drugs, as partial responses lead to recurrence, repeat dosing, and, eventually, overuse. Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Butalbital -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®